Merck
MRK
$111.07
Share price
-1.10%
Change (1 day)
20.69%
Change (1 year)
Categories
Merck (MRK) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : $63.10 B
According to Merck's latest financial reports the company's total liabilities are $63.10 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Merck - Total liabilities on balance sheet (from 2001 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $63.10 B | -6.43% |
| 2021-12-31 | $67.43 B | 1.89% |
| 2020-12-31 | $66.18 B | 13.34% |
| 2019-12-31 | $58.39 B | 4.74% |
| 2018-12-31 | $55.75 B | 4.6% |
| 2017-12-31 | $53.30 B | -3.21% |
| 2016-12-31 | $55.06 B | -3.41% |
| 2015-12-31 | $57.01 B | 15.07% |
| 2014-12-31 | $49.54 B | -7.08% |
| 2013-12-31 | $53.31 B | 5.23% |
| 2012-12-31 | $50.66 B | 5.16% |
| 2011-12-31 | $48.18 B | -1.62% |
| 2010-12-31 | $48.97 B | -3.2% |
| 2009-12-31 | $50.59 B | 94.39% |
| 2008-12-31 | $26.02 B | -6.23% |
| 2007-12-31 | $27.75 B | 12.82% |
| 2006-12-31 | $24.60 B | 0.33% |
| 2005-12-31 | $24.52 B | 7.19% |
| 2004-12-31 | $22.87 B | 8.45% |
| 2003-12-31 | $21.09 B | -13.66% |
| 2002-12-31 | $24.43 B | 5.68% |
| 2001-12-31 | $23.11 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $110.57 B | 75.23% | 🇺🇸 USA |
 Novartis NVS | $60.09 B | -4.76% | 🇨🇭 Switzerland |
 Pfizer PFE | $101.28 B | 60.52% | 🇺🇸 USA |
 Abbott Laboratories ABT | $37.53 B | -40.52% | 🇺🇸 USA |
 Eli Lilly LLY | $41.86 B | -33.65% | 🇺🇸 USA |
 Amgen AMGN | $83.37 B | 32.12% | 🇺🇸 USA |
 Sanofi SNY | $55.23 B | -12.47% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $62.39 B | -1.12% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.57 B | -7.18% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $35.31 B | -44.04% | 🇮🇱 Israel |